CBD Nutraceuticals Market By Product Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, and Others), By Sales Channel (Retail Stores, Online, and Pharmacies), and By Region - Trends, Analysis and Forecast till 2034

CBD Nutraceuticals Market was valued at USD 4.5 Billion in 2024 and is projected to grow at a CAGR of 16.4% to reach USD 17.9 Billion by 2034. 

Cannabinoids (CBD) is derived from plants called cannabis. Cannabis plant is a dioecious entity and includes a number of unique resorcinol metabolites. Later, it was found that cannabinoids also exist in other different plants, even in human body. In 1937, the U.S. criminalized the use of cannabis. This led to decreased consumption of cannabis. In past few years, there has been growing interest in the wide range of medical uses of cannabis and its constituents. However, laws and regulations are substantially different between countries globally. Laws differ between cannabis extracts, raw herbal cannabis, and cannabinoid-based medicines. Both the U.S. FDA and European Medicines Agency (EMA) have not approved the use of herbal cannabis or its extracts. The FDA has approved several cannabinoid-based medicines, as have 23 European countries, Canada, and Australia. In Australia, cannabis tenure and applications are currently illegal. But in several states and territories (South Australia, ACT, and Northern Territory) a small amount for personal use has been decriminalized. 

Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S.

On December 2018, Farm Bill was signed into law. The 2018 Farm Bill clearly preserved FDA’s authorities against hemp products. Therefore, hemp products should meet any applicable FDA standards and requirements, similar to any other FDA-regulated product. For example, FDA’s existing establishments over dietary supplements, foods, human and veterinary drugs, and cosmetics applies to hemp products to the extent such hemp products fall within those categories. These safeguards help ensure that Americans have access to safe and accurately labeled hemp products. Moreover, in the case of drugs, that patients can depend on the effectiveness of these products.

Scientific and business communities are experiencing unique challenges

The scientific and business communities are witnessing unique challenges in using cannabinoids as therapeutic agents. It includes low bioavailability and potentially erratic absorption in oral formulations, interactions with other drugs metabolized by the cytochrome P450 system, and significant accumulation in adipose and other tissues. Some of these difficulties can overcome by advanced novel delivery systems (transdermal, or mucosal) or through synthesis of related compounds with optimized properties. However, the presence of various alternatives, such as raspberry echinacea, ketones, garcinia, and Cambogia and turmeric, are projected to limit growth of the market over the forecast period.

The CBD nutraceuticals market is segmented based on product type, sales channel, and region.

On the basis of product type, the global CBD nutraceuticals market is segmented into CBD tinctures, capsules & softgels, CBD gummies, and others. Based on sales channel, the target market is segmented into retail stores, online, and pharmacies.

Regional Insights:

On region the CBD nutraceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to continue its dominance in terms of revenue share. This is mainly attributed to introduction of Farm Bill, which legalized cultivation of hemp and processing various hemp-derived products, growing number of health-conscious consumers, and rising presence of key players in the market.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the CBD Nutraceuticals Market report based on Product Type, Sales Channel and Region.

Global CBD Nutraceuticals Market, By Region:

• North America
  • U.S.
    • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the CBD nutraceuticals market includes Charlotte's Web, Elixinol, Medical Marijuana, Inc., CV Sciences, Inc., Irwin Naturals, and Diamond CBD. Charlotte's Web Holdings, Inc. Charlotte's Web Holdings, Inc. an innovative leader in the production and distribution of global hemp-derived cannabidiol wellness products. The company is involved into producing hemp-derived CBD extracts naturally containing a full spectrum of phytocannabinoids, involving CBD, terpenes, flavonoids and other beneficial hemp compounds.  Charlotte's Web product differentiated into CBD oil tinctures (liquid products), CBD topicals, CBD capsules, as well as CBD pet products. For instance, March 2020, the market leader in hemp-derived CBD extract products, declared the establishment of Charlotte's Web Labs (CW Labs). It’s an internal division for research & development substantially growing on the Company's efforts around the science of hemp derived terpenes, phytocannabinoids, and flavonoid compounds. 

• Charlotte's Web
• Elixinol, Medical Marijuana, Inc.
• CV Sciences, Inc.
• Irwin Naturals
• Diamond CBD